Last deal

$35M

Amount

Series B

Stage

03.10.2023

Date

2

all rounds

$60M

Total amount

General

About Company
Akura Medical is developing an easy-to-use thrombectomy device that removes blood clots efficiently.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Akura, Cunigence

founded date

01.01.2019

Number of employees

Last funding type

Series B

IPO status

Private

Description

Akura Medical offers medical devices, including thrombectomy devices, surgical, medical, dental, and veterinary apparatus and instruments, to help doctors treat venous thromboembolism (VTE) of all sizes in a more effective and efficient way. The company's next-generation thrombectomy device simplifies the procedure through a single-pass approach, making it easier for doctors to remove blood clots. With the goal of improving critical healthcare needs, Akura Medical's devices offer effective and easy-to-use clot removal.
Contacts